These final results, along with a earlier report exhibiting that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,2 assist the principle of targeting ACKR3 as a unique way to modulate the opioid program, which could open new therapeutic avenues for opioid-associated Issues. In combination with the described https://robertw680wsk8.blogofchange.com/profile